// App-Quantinova.ai

TCT-106 : Are Outcomes Following CABG for Left Main Disease Improving Over the Last Decade? A Propensity-Matched Analysis From the EXCEL and SYNTAX Randomized Trials

Researchers

Presenter

  • Patrick Serruys

Principal Investigators

  • Rodrigo Modolo

  • Taku Asano

  • Ply Chichareon

  • Ovidiu Dressler

  • Aaron Crowley

  • Ori Ben-Yehuda

  • John Puskas

  • David Taggart

  • A. Pieter Kappetein

  • Joseph Sabik

  • Yoshinobu Onuma

  • Gregg Stone

Medical Centers

  • Thorax Center, Erasmus Medical Center, Rotterdam, Netherlands

  • Cardiovascular Research Foundation, Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States

  • Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, United States

  • Academic Medical Center - Amsterdam, Amsterdam, Netherlands

  • John Radcliffe Hospital, Oxford, United Kingdom.

  • Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands

  • Mount Sinai, NY, New York, New York, United States

  • Cardiovascular Research Foundation, New York, New York, United States

  • Imperial College, London, United Kingdom

Locations

  • Netherlands

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Multi-vessel disease

  • Left main disease

  • Coronary Artery Disease

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A